State Street’s Sharps Compliance Corp SMED Stock Holding History

State Street’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-49,550	Closed	-$145K	–	4996
2022 Q2	$145K	Sell	49,550 -197,679	-80%	-$825K	﹤0.01%	4354
2022 Q1	$1.46M	Buy	247,229 +24,646	+11%	+$155K	﹤0.01%	3679
2021 Q4	$1.59M	Sell	222,583 -2,351	-1%	-$18K	﹤0.01%	3707
2021 Q3	$1.86M	Buy	224,934 +699	+0.3%	+$6.5K	﹤0.01%	3631
2021 Q2	$2.31M	Buy	224,235 +18,699	+9%	+$260K	﹤0.01%	3523
2021 Q1	$2.95M	Sell	205,536 -6,104	-3%	-$78.5K	﹤0.01%	3276
2020 Q4	$2M	Buy	211,640 +59,967	+40%	+$458K	﹤0.01%	3376
2020 Q3	$951K	Sell	151,673 -11,554	-7%	-$84K	﹤0.01%	3453
2020 Q2	$1.15M	Buy	+163,227	New	+$1.16M	﹤0.01%	3385

State Street's SMED Position: Q3 2022 in Review

State Street sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 49,550 shares — an estimated $145K sold.

State Street first reported a position in SMED in Q2 2020 and held it in 9 quarters. The position peaked at $2.95M in Q1 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

State Street reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
State Street sold 49,550 Sharps Compliance Corp shares in Q3 2022, an estimated $145K.
State Street first reported a position in Sharps Compliance Corp in Q2 2020 and held it in 9 quarters.
State Street's Sharps Compliance Corp position peaked at $2.95M in Q1 2021.
0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.